Biocon Q3 Results: Revenue up 9% YoY but misses estimates; exceptional loss weighs on profit

February 12, 2026
Uncategorized

Biocon’s Q3 revenue and EBITDA missed estimates, while profit rose sharply on a low base despite a ₹293 crore exceptional loss. The company also moved to fully integrate Biocon Biologics.

Biocon Q3 Results: Revenue up 9% YoY but misses estimates; exceptional loss weighs on profit

Leave a ReplyCancel Reply

US applications for jobless benefits fall to 227,000 last week, remaining at recent healthy levels

US homes sales fell sharply in January, even as mortgage rates continued to ease

Endurance Tech Q3 Results: Outpaces industry growth as GST-led demand lifts volumes

GAIL appoints Deepak Gupta as Chairman and Managing Director

Infosys, Wipro ADRs slide amid AI fears; US tech wobbles